PD-1 blockage as consolidation therapy after autologous stem cell transplant in patients with T-cell non-Hodgkin’s lymphoma shows improvements in progression-free survival
Autologous Hematopoietic Cell Transplantation: Way of the Future in Severe Systemic Sclerosis?
Although it would be too optimistic to call AHCT curative for SSc, it has thus far shown the most promise as a potential disease-modifying therapy.
Bortezomib-based Induction Therapy Before Transplant Benefits Amyloidosis Patients
A recent analysis of the institution’s use of bortezomib-based induction therapy prior to stem cell transplant in primary amyloidosis patients shows encouraging remission and survival rates.